Neurotrope Enters into Collaboration with the Nemours / Alfred I. duPont Hospital for Children to Initiate a Clinical Trial in Fragile X Syndrome Neurotrope Inc. (NASDAQ: NTRP) is announcing a collaboration with The Nemours / Alfred I. duPont Hospital for Children ("Nemours") to initiate a clinical trial in children with Fragile X Syndrome ("Fragile X"). READ MORE Read More pharmaceutical, alzheimersIntuitive Venture PartnersSeptember 5, 2018neurotrope, 2018
